Skip to Content

raloxifene FDA Alerts

The FDA Alert(s) below may be specifically about raloxifene or relate to a group or class of drugs which include raloxifene.

MedWatch Safety Alerts are distributed by the FDA and published by Following is a list of possible medication recalls, market withdrawals, alerts and warnings. For the latest FDA MedWatch alerts, go here.

Recent FDA Alert(s) for raloxifene

Counterfeit Drugs Purchased in Mexico

May 11, 2005

Audience: Healthcare professionals and consumers

The FDA warned the public about the sale of counterfeit versions of Lipitor, Viagra, and an unapproved product promoted as "generic Evista" to U.S. consumers at pharmacies in Mexican border towns. The "generic Evista" was analyzed by FDA in coordination with the National Association of Boards of Pharmacy and was found to contain no active ingredient. The counterfeit Lipitor and counterfeit Viagra were analyzed by Pfizer, Inc. and were also found to contain no active ingredient. Consumers who have any of these counterfeit products should not use them and should contact their healthcare provider immediately.

[May 10, 2005 - Talk Paper - FDA]

More raloxifene Resources